| Year |
Citation |
Score |
| 2023 |
Filioglou D, Husnain M, Khurana S, Simpson RJ, Katsanis E. Has the shortage of fludarabine altered the current paradigm of lymphodepletion in favor of bendamustine? Frontiers in Immunology. 14: 1329850. PMID 38077398 DOI: 10.3389/fimmu.2023.1329850 |
0.359 |
|
| 2023 |
Eylon M, Prabhu S, John S, King MJM, Bhatt D, Curran KJ, Erickson C, Karras NA, Phillips CL, Satwani P, Hermiston M, Southworth E, Baumeister SHC, Talano JA, MacMillan ML, ... ... Katsanis E, et al. Mediport use as an acceptable standard for CAR T cell infusion. Frontiers in Immunology. 14: 1239132. PMID 37965315 DOI: 10.3389/fimmu.2023.1239132 |
0.317 |
|
| 2023 |
Batatinha H, Diak DM, Niemiro GM, Baker FL, Smith KA, Zúñiga TM, Mylabathula PL, Seckeler MD, Lau B, LaVoy EC, Gustafson MP, Katsanis E, Simpson RJ. Human lymphocytes mobilized with exercise have an anti-tumor transcriptomic profile and exert enhanced graft-versus-leukemia effects in xenogeneic mice. Frontiers in Immunology. 14: 1067369. PMID 37077913 DOI: 10.3389/fimmu.2023.1067369 |
0.315 |
|
| 2023 |
Gilman KE, Matiatos AP, Cracchiolo MJ, Moon AG, Davini DW, Simpson RJ, Katsanis E. Multiagent Intratumoral Immunotherapy Can Be Effective in A20 Lymphoma Clearance and Generation of Systemic T Cell Immunity. Cancers. 15. PMID 37046612 DOI: 10.3390/cancers15071951 |
0.429 |
|
| 2023 |
Baker FL, Zúñiga TM, Smith KA, Batatinha H, Kulangara TS, Seckeler MD, Burgess SC, Katsanis E, Simpson RJ. Exercise mobilizes diverse antigen specific T-cells and elevates neutralizing antibodies in humans with natural immunity to SARS CoV-2. Brain, Behavior, & Immunity - Health. 28: 100600. PMID 36743994 DOI: 10.1016/j.bbih.2023.100600 |
0.34 |
|
| 2022 |
Zúñiga TM, Baker FL, Smith KA, Batatinha H, Lau B, Gustafson MP, Katsanis E, Simpson RJ. Acute exercise mobilizes NKT-like cells with a cytotoxic transcriptomic profile but does not augment the potency of cytokine-induced killer (CIK) cells. Frontiers in Immunology. 13: 938106. PMID 36189306 DOI: 10.3389/fimmu.2022.938106 |
0.361 |
|
| 2022 |
Molina MS, Hoffman EA, Stokes J, Kummet N, Simpson RJ, Katsanis E. Murine precursors to type 1 conventional dendritic cells induce tumor cytotoxicity and exhibit activated PD-1/PD-L1 pathway. Plos One. 17: e0273075. PMID 35980974 DOI: 10.1371/journal.pone.0273075 |
0.441 |
|
| 2022 |
Stokes J, Simpson RJ, Katsanis E. Commentary: Post-Transplantation Cyclophosphamide Uniquely Restrains Alloreactive CD4+ T-Cell Proliferation and Differentiation After Murine MHC-Haploidentical Hematopoietic Cell Transplantation. Frontiers in Immunology. 13: 887648. PMID 35493453 DOI: 10.3389/fimmu.2022.887648 |
0.325 |
|
| 2021 |
Baker FL, Smith KA, Zúñiga TM, Batatinha H, Niemiro GM, Pedlar CR, Burgess SC, Katsanis E, Simpson RJ. Acute exercise increases immune responses to SARS CoV-2 in a previously infected man. Brain, Behavior, & Immunity - Health. 100343. PMID 34514439 DOI: 10.1016/j.bbih.2021.100343 |
0.317 |
|
| 2021 |
Pariury H, Truscott L, Katsanis E. Have CD19-directed immunotherapy and haploidentical hematopoietic cell transplantation transformed pediatric B-cell acute lymphoblastic leukemia into a chronic disease? Oncoimmunology. 10: 1956125. PMID 34367735 DOI: 10.1080/2162402X.2021.1956125 |
0.335 |
|
| 2021 |
Molina MS, Hoffman EA, Stokes J, Kummet N, Smith KA, Baker F, Zúñiga TM, Simpson RJ, Katsanis E. Regulatory Dendritic Cells Induced by Bendamustine Are Associated With Enhanced Flt3 Expression and Alloreactive T-Cell Death. Frontiers in Immunology. 12: 699128. PMID 34249005 DOI: 10.3389/fimmu.2021.699128 |
0.409 |
|
| 2021 |
Stokes J, Molina MS, Hoffman EA, Simpson RJ, Katsanis E. Immunomodulatory Effects of Bendamustine in Hematopoietic Cell Transplantation. Cancers. 13. PMID 33916711 DOI: 10.3390/cancers13071702 |
0.415 |
|
| 2020 |
Kunz HE, Agha NH, Hussain M, LaVoy EC, Smith KA, Mylabathula P, Diak D, Baker FL, O'Connor DP, Bond RA, Katsanis E, Bollard CM, Simpson RJ. The effects of β and β adrenergic receptor blockade on the exercise-induced mobilization and ex vivo expansion of virus-specific T cells: implications for cellular therapy and the anti-viral immune effects of exercise. Cell Stress & Chaperones. PMID 32779001 DOI: 10.1007/S12192-020-01136-7 |
0.309 |
|
| 2020 |
Molina MS, Stokes J, Hoffman EA, Eremija J, Zeng Y, Simpson RJ, Katsanis E. Bendamustine Conditioning Skews Murine Host DCs Toward Pre-cDC1s and Reduces GvHD Independently of Batf3. Frontiers in Immunology. 11: 1410. PMID 32765499 DOI: 10.3389/Fimmu.2020.01410 |
0.533 |
|
| 2020 |
Katsanis E, Sapp LN, Reid SC, Reddivalla N, Stea B. T-Cell Replete Myeloablative Haploidentical Bone Marrow Transplantation Is an Effective Option for Pediatric and Young Adult Patients With High-Risk Hematologic Malignancies. Frontiers in Pediatrics. 8: 282. PMID 32582591 DOI: 10.3389/Fped.2020.00282 |
0.336 |
|
| 2020 |
Stokes J, Hoffman EA, Molina MS, Kummet N, Simpson RJ, Zeng Y, Katsanis E. Bendamustine with total body irradiation conditioning yields tolerant T-cells while preserving T-cell-dependent graft-versus-leukemia. Oncoimmunology. 9: 1758011. PMID 32391190 DOI: 10.1080/2162402X.2020.1758011 |
0.555 |
|
| 2019 |
Baker FL, Bigley AB, Agha NH, Pedlar CR, O'Connor DP, Bond RA, Bollard CM, Katsanis E, Simpson RJ. Systemic β-Adrenergic Receptor Activation Augments the Expansion and Anti-Tumor Activity of Vγ9Vδ2 T-Cells. Frontiers in Immunology. 10: 3082. PMID 32038628 DOI: 10.3389/Fimmu.2019.03082 |
0.452 |
|
| 2019 |
Katsanis E, Stokes J, Hoffman E, Maher KR, Kodali MK, Anwer F, McBride A, Roe D, Zeng Y, Simpson R. A Phase I Study of Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide and/or Bendamustine Biology of Blood and Marrow Transplantation. 25: S224. DOI: 10.1016/J.Bbmt.2018.12.212 |
0.325 |
|
| 2018 |
Stokes J, Hoffman EA, Molina MS, Eremija J, Larmonier N, Zeng Y, Katsanis E. Bendamustine with total body irradiation limits murine graft-versus-host disease in part through effects on myeloid-derived suppressor cells. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 30326280 DOI: 10.1016/J.Bbmt.2018.10.009 |
0.48 |
|
| 2018 |
Graff RM, Kunz HE, Agha NH, Baker FL, Laughlin M, Bigley AB, Markofski MM, LaVoy EC, Katsanis E, Bond RA, Bollard CM, Simpson RJ. βadrenergic receptor signaling mediates the preferential mobilization of differentiated subsets of CD8+ T-cells, NK-cells and non-classical monocytes in response to acute exercise in humans. Brain, Behavior, and Immunity. PMID 30172948 DOI: 10.1016/J.Bbi.2018.08.017 |
0.43 |
|
| 2018 |
Katsanis E, Sapp LN, Varner N, Koza S, Stea B, Zeng Y. Haploidentical bone marrow transplantation with post-transplant cyclophosphamide/bendamustine in pediatric and young adult patients with hematologic malignancies. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 29908231 DOI: 10.1016/J.Bbmt.2018.06.007 |
0.421 |
|
| 2018 |
Hoffman E, Stokes J, Molina MS, Katsanis E. Bendamustine with Total Body Irradiation Limits Murine Graft-Versus-Host Disease in Part Via Myeloid-Derived Suppressor Cells Blood. 132: 2040-2040. DOI: 10.1182/Blood-2018-99-117512 |
0.328 |
|
| 2018 |
Molina MS, Stokes J, Hoffman E, Katsanis E. Bendamustine Conditioning Alters Host Dendritic Cell Composition and Function Blood. 132: 5670-5670. DOI: 10.1182/Blood-2018-99-117140 |
0.349 |
|
| 2018 |
Durer S, Durer C, Katsanis E, Comba IY, Jamil F, Aslam S, Shah Z, Malik MN, Selene II, Fraz MA, Jose JA, Qureshi A, Yasir M, Amin SN, Anwer F. Outcomes of T-Cell Depleted Haploidentical Peripheral Blood Stem Cell Transplantation for Adult Acute Leukemia: A Meta-Analysis Blood. 132: 5779-5779. DOI: 10.1182/Blood-2018-99-115592 |
0.396 |
|
| 2017 |
Zeng Y, Hahn S, Stokes J, Hoffman EA, Schmelz M, Proytcheva M, Chernoff J, Katsanis E. Pak2 regulates myeloid-derived suppressor cell development in mice. Blood Advances. 1: 1923-1933. PMID 29296839 DOI: 10.1182/Bloodadvances.2017007435 |
0.643 |
|
| 2017 |
Zeng Y, Katsanis E. Potential niche indications for blinatumomab as a bridge to hematopoietic cell transplantation. Bone Marrow Transplantation. PMID 28920946 DOI: 10.1038/Bmt.2017.186 |
0.44 |
|
| 2017 |
Kanate AS, DiGilio A, Ahn KW, Al Malki M, Jacobsen E, Steinberg A, Hamerschlak N, Kharfan-Dabaja M, Salit R, Ball E, Bashir Q, Cashen A, Couriel D, Diez-Martin J, Katsanis E, et al. Allogeneic haematopoietic cell transplantation for extranodal natural killer/T-cell lymphoma, nasal type: a CIBMTR analysis. British Journal of Haematology. PMID 28771676 DOI: 10.1111/Bjh.14879 |
0.324 |
|
| 2016 |
Katsanis E, Sapp LN, Pelayo-Katsanis L, Whitney K, Zeng Y, Kopp LM. Alternative Donor Hematopoietic Cell Transplantation Conditioned With Myeloablative Busulfan, Fludarabine, and Melphalan is Well Tolerated and Effective Against High-risk Myeloid Malignancies. Journal of Pediatric Hematology/Oncology. PMID 27467368 DOI: 10.1097/Mph.0000000000000621 |
0.423 |
|
| 2016 |
Kopp LM, Katsanis E. Targeted immunotherapy for pediatric solid tumors. Oncoimmunology. 5: e1087637. PMID 27141344 DOI: 10.1080/2162402X.2015.1087637 |
0.375 |
|
| 2016 |
Stokes J, Hoffman EA, Zeng Y, Larmonier N, Katsanis E. Post-transplant bendamustine reduces GvHD while preserving GvL in experimental haploidentical bone marrow transplantation. British Journal of Haematology. PMID 27030315 DOI: 10.1111/Bjh.14034 |
0.458 |
|
| 2016 |
Zeng Y, Hahn S, Stokes J, Hoffman E, Chernoff J, Katsanis E. Pak2 Regulates MDSC Development and Function Blood. 128: 705-705. DOI: 10.1182/Blood.V128.22.705.705 |
0.498 |
|
| 2015 |
Trad M, Gautheron A, Fraszczak J, Alizadeh D, Larmonier C, LaCasse CJ, Centuori S, Audia S, Samson M, Ciudad M, Bonnefoy F, Lemaire-Ewing S, Katsanis E, Perruche S, Saas P, et al. T Lymphocyte Inhibition by Tumor-Infiltrating Dendritic Cells Involves Ectonucleotidase CD39 but Not Arginase-1. Biomed Research International. 2015: 891236. PMID 26491691 DOI: 10.1155/2015/891236 |
0.826 |
|
| 2015 |
Zeng Y, Katsanis E. The complex pathophysiology of acquired aplastic anaemia. Clinical and Experimental Immunology. 180: 361-70. PMID 25683099 DOI: 10.1111/Cei.12605 |
0.598 |
|
| 2014 |
Graner MW, Lillehei KO, Katsanis E. Endoplasmic reticulum chaperones and their roles in the immunogenicity of cancer vaccines. Frontiers in Oncology. 4: 379. PMID 25610811 DOI: 10.3389/Fonc.2014.00379 |
0.45 |
|
| 2014 |
Lund TC, Cathey SS, Miller WP, Eapen M, Andreansky M, Dvorak CC, Davis JH, Dalal JD, Devine SM, Eames GM, Ferguson WS, Giller RH, He W, Kurtzberg J, Krance R, ... Katsanis E, et al. Outcomes after hematopoietic stem cell transplantation for children with I-cell disease. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 20: 1847-51. PMID 25016194 DOI: 10.1016/J.Bbmt.2014.06.019 |
0.303 |
|
| 2014 |
Hanke NT, LaCasse CJ, Larmonier CB, Alizadeh D, Trad M, Janikashvili N, Bonnotte B, Katsanis E, Larmonier N. PIAS1 and STAT-3 impair the tumoricidal potential of IFN-γ-stimulated mouse dendritic cells generated with IL-15. European Journal of Immunology. 44: 2489-99. PMID 24777831 DOI: 10.1002/Eji.201343803 |
0.767 |
|
| 2014 |
Zeng Y, Stokes J, Hahn S, Hoffman E, Katsanis E. Activated MHC-mismatched T helper-1 lymphocyte infusion enhances GvL with limited GvHD. Bone Marrow Transplantation. 49: 1076-83. PMID 24777185 DOI: 10.1038/Bmt.2014.91 |
0.6 |
|
| 2014 |
Alizadeh D, Katsanis E, Larmonier N. Chemotherapeutic targeting of myeloid-derived suppressor cells. Oncoimmunology. 3: e27359. PMID 24653963 DOI: 10.4161/Onci.27359 |
0.517 |
|
| 2014 |
Alizadeh D, Trad M, Hanke NT, Larmonier CB, Janikashvili N, Bonnotte B, Katsanis E, Larmonier N. Doxorubicin eliminates myeloid-derived suppressor cells and enhances the efficacy of adoptive T-cell transfer in breast cancer. Cancer Research. 74: 104-18. PMID 24197130 DOI: 10.1158/0008-5472.Can-13-1545 |
0.845 |
|
| 2014 |
Alizadeh D, Katsanis E, Larmonier N. Abstract 150: Role of reactive oxygen species in doxorubicin-induced apoptosis of myeloid-derived suppressor cells Cancer Research. 74: 150-150. DOI: 10.1158/1538-7445.Am2014-150 |
0.569 |
|
| 2013 |
Alizadeh D, Katsanis E, Larmonier N. The multifaceted role of Th17 lymphocytes and their associated cytokines in cancer. Clinical & Developmental Immunology. 2013: 957878. PMID 24454480 DOI: 10.1155/2013/957878 |
0.536 |
|
| 2013 |
Epple LM, Bemis LT, Cavanaugh RP, Skope A, Mayer-Sonnenfeld T, Frank C, Olver CS, Lencioni AM, Dusto NL, Tal A, Har-Noy M, Lillehei KO, Katsanis E, Graner MW. Prolonged remission of advanced bronchoalveolar adenocarcinoma in a dog treated with autologous, tumour-derived chaperone-rich cell lysate (CRCL) vaccine. International Journal of Hyperthermia : the Official Journal of European Society For Hyperthermic Oncology, North American Hyperthermia Group. 29: 390-8. PMID 23786302 DOI: 10.3109/02656736.2013.800997 |
0.31 |
|
| 2013 |
Graner MW, Romanoski A, Katsanis E. The 'peptidome' of tumour-derived chaperone-rich cell lysate anti-cancer vaccines reveals potential tumour antigens that stimulate tumour immunity. International Journal of Hyperthermia : the Official Journal of European Society For Hyperthermic Oncology, North American Hyperthermia Group. 29: 380-9. PMID 23725202 DOI: 10.3109/02656736.2013.793406 |
0.37 |
|
| 2013 |
Hanke N, Alizadeh D, Katsanis E, Larmonier N. Dendritic cell tumor killing activity and its potential applications in cancer immunotherapy. Critical Reviews in Immunology. 33: 1-21. PMID 23510023 DOI: 10.1615/Critrevimmunol.2013006679 |
0.847 |
|
| 2013 |
Alizadeh D, Trad M, Katsanis E, Larmonier N. Abstract 4740: Doxorubicin eliminates tumor-induced myeloid-derived suppressor cells and enhances T-helper lymphocyte-based immunotherapy in a murine breast cancer model. Cancer Research. 73: 4740-4740. DOI: 10.1158/1538-7445.Am2013-4740 |
0.61 |
|
| 2013 |
Larmonier N, Katsanis E. Dendritic cells for cancer immunotherapy Emerging Trends in Cell and Gene Therapy. 251-270. DOI: 10.1007/978-1-62703-417-3_11 |
0.531 |
|
| 2012 |
Centuori SM, Trad M, LaCasse CJ, Alizadeh D, Larmonier CB, Hanke NT, Kartchner J, Janikashvili N, Bonnotte B, Larmonier N, Katsanis E. Myeloid-derived suppressor cells from tumor-bearing mice impair TGF-β-induced differentiation of CD4+CD25+FoxP3+ Tregs from CD4+CD25-FoxP3- T cells. Journal of Leukocyte Biology. 92: 987-97. PMID 22891289 DOI: 10.1189/Jlb.0911465 |
0.778 |
|
| 2012 |
Larmonier N, Bonnotte B, Katsanis E. Cytotoxic and antigen presenting functions of T helper-1-activated dendritic cells. Oncoimmunology. 1: 566-568. PMID 22754789 DOI: 10.4161/Onci.19370 |
0.577 |
|
| 2011 |
Janikashvili N, Bonnotte B, Katsanis E, Larmonier N. The dendritic cell-regulatory T lymphocyte crosstalk contributes to tumor-induced tolerance. Clinical & Developmental Immunology. 2011: 430394. PMID 22110524 DOI: 10.1155/2011/430394 |
0.611 |
|
| 2011 |
LaCasse CJ, Janikashvili N, Larmonier CB, Alizadeh D, Hanke N, Kartchner J, Situ E, Centuori S, Har-Noy M, Bonnotte B, Katsanis E, Larmonier N. Th-1 lymphocytes induce dendritic cell tumor killing activity by an IFN-γ-dependent mechanism. Journal of Immunology (Baltimore, Md. : 1950). 187: 6310-7. PMID 22075702 DOI: 10.4049/Jimmunol.1101812 |
0.796 |
|
| 2011 |
Audia S, Samson M, Guy J, Janikashvili N, Fraszczak J, Trad M, Ciudad M, Leguy V, Berthier S, Petrella T, Aho-Glélé S, Martin L, Maynadié M, Lorcerie B, Rat P, ... ... Katsanis E, et al. Immunologic effects of rituximab on the human spleen in immune thrombocytopenia. Blood. 118: 4394-400. PMID 21876120 DOI: 10.1182/Blood-2011-03-344051 |
0.466 |
|
| 2011 |
Lakomy D, Janikashvili N, Fraszczak J, Trad M, Audia S, Samson M, Ciudad M, Vinit J, Vergely C, Caillot D, Foucher P, Lagrost L, Chouaib S, Katsanis E, Larmonier N, et al. Cytotoxic dendritic cells generated from cancer patients. Journal of Immunology (Baltimore, Md. : 1950). 187: 2775-82. PMID 21804019 DOI: 10.4049/Jimmunol.1004146 |
0.565 |
|
| 2011 |
Janikashvili N, LaCasse CJ, Larmonier C, Trad M, Herrell A, Bustamante S, Bonnotte B, Har-Noy M, Larmonier N, Katsanis E. Allogeneic effector/memory Th-1 cells impair FoxP3+ regulatory T lymphocytes and synergize with chaperone-rich cell lysate vaccine to treat leukemia. Blood. 117: 1555-64. PMID 21123824 DOI: 10.1182/Blood-2010-06-288621 |
0.847 |
|
| 2010 |
Janikashvili N, Larmonier N, Katsanis E. Personalized dendritic cell-based tumor immunotherapy. Immunotherapy. 2: 57-68. PMID 20161666 DOI: 10.2217/Imt.09.78 |
0.511 |
|
| 2010 |
Fraszczak J, Trad M, Janikashvili N, Cathelin D, Lakomy D, Granci V, Morizot A, Audia S, Micheau O, Lagrost L, Katsanis E, Solary E, Larmonier N, Bonnotte B. Peroxynitrite-dependent killing of cancer cells and presentation of released tumor antigens by activated dendritic cells. Journal of Immunology (Baltimore, Md. : 1950). 184: 1876-84. PMID 20089706 DOI: 10.4049/Jimmunol.0900831 |
0.598 |
|
| 2010 |
Cantrell J, Larmonier C, Janikashvili N, Bustamante S, Fraszczak J, Herrell A, Lundeen T, J LaCasse C, Situ E, Larmonier N, Katsanis E. Signaling pathways induced by a tumor-derived vaccine in antigen presenting cells. Immunobiology. 215: 535-44. PMID 19880213 DOI: 10.1016/J.Imbio.2009.09.006 |
0.718 |
|
| 2010 |
Larmonier N, Fraszczak J, Lakomy D, Bonnotte B, Katsanis E. Killer dendritic cells and their potential for cancer immunotherapy. Cancer Immunology, Immunotherapy : Cii. 59: 1-11. PMID 19618185 DOI: 10.1007/S00262-009-0736-1 |
0.615 |
|
| 2008 |
Larmonier N, Janikashvili N, LaCasse CJ, Larmonier CB, Cantrell J, Situ E, Lundeen T, Bonnotte B, Katsanis E. Imatinib mesylate inhibits CD4+ CD25+ regulatory T cell activity and enhances active immunotherapy against BCR-ABL- tumors. Journal of Immunology (Baltimore, Md. : 1950). 181: 6955-63. PMID 18981115 DOI: 10.4049/Jimmunol.181.10.6955 |
0.831 |
|
| 2008 |
Bleifuss E, Bendz H, Sirch B, Thompson S, Brandl A, Milani V, Graner MW, Drexler I, Kuppner M, Katsanis E, Noessner E, Issels RD. Differential capacity of chaperone-rich lysates in cross-presenting human endogenous and exogenous melanoma differentiation antigens. International Journal of Hyperthermia : the Official Journal of European Society For Hyperthermic Oncology, North American Hyperthermia Group. 24: 623-37. PMID 18608582 DOI: 10.1080/02656730802213384 |
0.536 |
|
| 2008 |
Li G, Andreansky S, Helguera G, Sepassi M, Janikashvili N, Cantrell J, Lacasse CL, Larmonier N, Penichet ML, Katsanis E. A chaperone protein-enriched tumor cell lysate vaccine generates protective humoral immunity in a mouse breast cancer model. Molecular Cancer Therapeutics. 7: 721-9. PMID 18347157 DOI: 10.1158/1535-7163.Mct-07-2067 |
0.696 |
|
| 2008 |
Larmonier N, Cantrell J, Lacasse C, Li G, Janikashvili N, Situ E, Sepassi M, Andreansky S, Katsanis E. Chaperone-rich tumor cell lysate-mediated activation of antigen-presenting cells resists regulatory T cell suppression. Journal of Leukocyte Biology. 83: 1049-59. PMID 18174364 DOI: 10.1189/Jlb.0907635 |
0.842 |
|
| 2007 |
Larmonier N, Cathelin D, Larmonier C, Nicolas A, Merino D, Janikashvili N, Audia S, Bateman A, Thompson J, Kottke T, Hartung T, Katsanis E, Vile R, Bonnotte B. The inhibition of TNF-alpha anti-tumoral properties by blocking antibodies promotes tumor growth in a rat model. Experimental Cell Research. 313: 2345-55. PMID 17466973 DOI: 10.1016/J.Yexcr.2007.03.027 |
0.413 |
|
| 2007 |
Li G, Zeng Y, Chen X, Larmonier N, Sepassi M, Graner MW, Andreansky S, Brewer MA, Katsanis E. Human ovarian tumour-derived chaperone-rich cell lysate (CRCL) elicits T cell responses in vitro. Clinical and Experimental Immunology. 148: 136-45. PMID 17349014 DOI: 10.1111/J.1365-2249.2007.03323.X |
0.565 |
|
| 2007 |
Kislin KL, Marron MT, Li G, Graner MW, Katsanis E. Chaperone-rich cell lysate embedded with BCR-ABL peptide demonstrates enhanced anti-tumor activity against a murine BCR-ABL positive leukemia. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 21: 2173-84. PMID 17327358 DOI: 10.1096/Fj.06-7843Com |
0.802 |
|
| 2007 |
Chen X, Zhou B, Li M, Deng Q, Wu X, Le X, Wu C, Larmonier N, Zhang W, Zhang H, Wang H, Katsanis E. CD4(+)CD25(+)FoxP3(+) regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease. Clinical Immunology (Orlando, Fla.). 123: 50-9. PMID 17234458 DOI: 10.1016/J.Clim.2006.11.009 |
0.467 |
|
| 2007 |
Larmonier N, Marron M, Zeng Y, Cantrell J, Romanoski A, Sepassi M, Thompson S, Chen X, Andreansky S, Katsanis E. Tumor-derived CD4(+)CD25(+) regulatory T cell suppression of dendritic cell function involves TGF-beta and IL-10. Cancer Immunology, Immunotherapy : Cii. 56: 48-59. PMID 16612596 DOI: 10.1007/S00262-006-0160-8 |
0.725 |
|
| 2006 |
Zeng Y, Chen X, Larmonier N, Larmonier C, Li G, Sepassi M, Marron M, Andreansky S, Katsanis E. Natural killer cells play a key role in the antitumor immunity generated by chaperone-rich cell lysate vaccination. International Journal of Cancer. Journal International Du Cancer. 119: 2624-31. PMID 16989012 DOI: 10.1002/Ijc.22150 |
0.646 |
|
| 2006 |
Larmonier N, Mérino D, Nicolas A, Cathelin D, Besson A, Bateman A, Solary E, Martin F, Katsanis E, Bonnotte B. Apoptotic, necrotic, or fused tumor cells: an equivalent source of antigen for dendritic cell loading. Apoptosis : An International Journal On Programmed Cell Death. 11: 1513-24. PMID 16738802 DOI: 10.1007/S10495-006-8765-0 |
0.495 |
|
| 2006 |
Chen X, Zeng Y, Li G, Larmonier N, Graner MW, Katsanis E. Peritransplantation vaccination with chaperone-rich cell lysate induces antileukemia immunity. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 12: 275-83. PMID 16503496 DOI: 10.1016/J.Bbmt.2006.01.001 |
0.559 |
|
| 2006 |
Ramanathapuram LV, Hahn T, Graner MW, Katsanis E, Akporiaye ET. Vesiculated alpha-tocopheryl succinate enhances the anti-tumor effect of dendritic cell vaccines. Cancer Immunology, Immunotherapy : Cii. 55: 166-77. PMID 16041582 DOI: 10.1007/S00262-005-0016-7 |
0.349 |
|
| 2006 |
Zeng Y, Graner MW, Katsanis E. Chaperone-rich cell lysates, immune activation and tumor vaccination. Cancer Immunology, Immunotherapy : Cii. 55: 329-38. PMID 15887013 DOI: 10.1007/S00262-005-0694-1 |
0.647 |
|
| 2005 |
Zeng Y, Graner MW, Thompson S, Marron M, Katsanis E. Induction of BCR-ABL-specific immunity following vaccination with chaperone-rich cell lysates derived from BCR-ABL+ tumor cells. Blood. 105: 2016-22. PMID 15374884 DOI: 10.1182/Blood-2004-05-1915 |
0.491 |
|
| 2004 |
Graner MW, Likhacheva A, Davis J, Raymond A, Brandenberger J, Romanoski A, Thompson S, Akporiaye E, Katsanis E. Cargo from tumor-expressed albumin inhibits T-cell activation and responses. Cancer Research. 64: 8085-92. PMID 15520220 DOI: 10.1158/0008-5472.Can-04-1871 |
0.406 |
|
| 2004 |
Feng H, Zeng Y, Graner MW, Whitesell L, Katsanis E. Evidence for a Novel, Caspase-8-Independent, Fas Death Domain-Mediated Apoptotic Pathway. Journal of Biomedicine & Biotechnology. 2004: 41-51. PMID 15123887 DOI: 10.1155/S1110724304308041 |
0.583 |
|
| 2004 |
Zeng Y, Graner MW, Feng H, Li G, Katsanis E. Imatinib mesylate effectively combines with chaperone-rich cell lysate-loaded dendritic cells to treat bcr-abl+ murine leukemia. International Journal of Cancer. Journal International Du Cancer. 110: 251-9. PMID 15069690 DOI: 10.1002/Ijc.20115 |
0.715 |
|
| 2004 |
Chen X, Zeng Y, Li G, Thompson S, Sepassi M, Romanoski MA, Graner MW, Katsanis E. Tumor-Derived Chaperone-Rich Cell Lysate (CRCL) Can Be Effectively Combined with Syngeneic Bone Marrow Transplantation to Treat Bcr-abl+ Leukemia in a Murine Model. Blood. 104: 2971-2971. DOI: 10.1182/Blood.V104.11.2971.2971 |
0.476 |
|
| 2004 |
Li G, Zeng Y, Chen X, Sepassi M, Romanoski A, Thompson S, Graner M, Brewer M, Katsanis E. Human Ovarian Tumor-Derived Chaperone-Rich Cell Lysates Activate Dentdritic Cells and Elicit T Cell Responses In Vitro Journal of Immunotherapy. 27: S26-S27. DOI: 10.1097/00002371-200411000-00097 |
0.52 |
|
| 2003 |
Graner MW, Zeng Y, Feng H, Katsanis E. Tumor-derived chaperone-rich cell lysates are effective therapeutic vaccines against a variety of cancers. Cancer Immunology, Immunotherapy : Cii. 52: 226-34. PMID 12669247 DOI: 10.1007/S00262-002-0359-2 |
0.668 |
|
| 2003 |
Zeng Y, Feng H, Graner MW, Katsanis E. Tumor-derived, chaperone-rich cell lysate activates dendritic cells and elicits potent antitumor immunity. Blood. 101: 4485-91. PMID 12576309 DOI: 10.1182/Blood-2002-10-3108 |
0.763 |
|
| 2003 |
Feng H, Zeng Y, Graner MW, Likhacheva A, Katsanis E. Exogenous stress proteins enhance the immunogenicity of apoptotic tumor cells and stimulate antitumor immunity. Blood. 101: 245-52. PMID 12393411 DOI: 10.1182/Blood-2002-05-1580 |
0.748 |
|
| 2002 |
Feng H, Zeng Y, Graner MW, Katsanis E. Stressed apoptotic tumor cells stimulate dendritic cells and induce specific cytotoxic T cells. Blood. 100: 4108-15. PMID 12393401 DOI: 10.1182/Blood-2002-05-1389 |
0.72 |
|
| 2001 |
Feng H, Zeng Y, Whitesell L, Katsanis E. Stressed apoptotic tumor cells express heat shock proteins and elicit tumor-specific immunity. Blood. 97: 3505-12. PMID 11369644 DOI: 10.1182/Blood.V97.11.3505 |
0.71 |
|
| 2001 |
He L, Feng H, Raymond A, Kreeger M, Zeng Y, Graner M, Whitesell L, Katsanis E. Dendritic-cell-peptide immunization provides immunoprotection against bcr-abl-positive leukemia in mice. Cancer Immunology, Immunotherapy : Cii. 50: 31-40. PMID 11315508 DOI: 10.1007/Pl00006680 |
0.71 |
|
| 2001 |
McEarchern JA, Kobie JJ, Mack V, Wu RS, Meade-Tollin L, Arteaga CL, Dumont N, Besselsen D, Seftor E, Hendrix MJ, Katsanis E, Akporiaye ET. Invasion and metastasis of a mammary tumor involves TGF-beta signaling. International Journal of Cancer. 91: 76-82. PMID 11149423 DOI: 10.1002/1097-0215(20010101)91:1<76::Aid-Ijc1012>3.0.Co;2-8 |
0.301 |
|
| 2000 |
Graner M, Raymond A, Akporiaye E, Katsanis E. Tumor-derived multiple chaperone enrichment by free-solution isoelectric focusing yields potent antitumor vaccines Cancer Immunology Immunotherapy. 49: 476-484. PMID 11092614 DOI: 10.1007/S002620000138 |
0.425 |
|
| 2000 |
Graner M, Raymond A, Romney D, He L, Whitesell L, Katsanis E. Immunoprotective activities of multiple chaperone proteins isolated from murine B-cell leukemia/lymphoma Clinical Cancer Research. 6: 909-915. PMID 10741715 |
0.356 |
|
| 2000 |
Yorgin PD, Hartson SD, Fellah AM, Scroggins BT, Huang W, Katsanis E, Couchman JM, Matts RL, Whitesell L. Effects of geldanamycin, a heat-shock protein 90-binding agent, on T cell function and T cell nonreceptor protein tyrosine kinases. Journal of Immunology (Baltimore, Md. : 1950). 164: 2915-23. PMID 10706677 DOI: 10.4049/Jimmunol.164.6.2915 |
0.366 |
|
| 1999 |
Perentesis JP, Katsanis E, DeFor TE, Neglia JP, Ramsay NKC. Autologous stem cell transplantation for high-risk pediatric solid tumors Bone Marrow Transplantation. 24: 609-615. PMID 10490725 DOI: 10.1038/Sj.Bmt.1701950 |
0.34 |
|
| 1998 |
Katsanis E, Weisdorf DJ, Miller JS. Activated peripheral blood mononuclear cells from patients receiving subcutaneous interleukin-2 following autologous stem cell transplantation prolong survival of SCID mice bearing human lymphoma Bone Marrow Transplantation. 22: 185-191. PMID 9707028 DOI: 10.1038/Sj.Bmt.1701307 |
0.41 |
|
| 1997 |
Xu Z, Katsanis E. Improved immunostimulatory function of bone marrow derived macrophages transduced with the granulocyte-macrophage colony stimulating factor gene Cancer Biotherapy and Radiopharmaceuticals. 12: 27-36. PMID 10851444 DOI: 10.1089/Cbr.1997.12.27 |
0.425 |
|
| 1997 |
Boyer MW, Vallera DA, Taylor PA, Gray GS, Katsanis E, Gorden K, Orchard PJ, Blazar BR. The role of B7 costimulation by murine acute myeloid leukemia in the generation and function of a CD8+T-cell line with potent in vivo graft-versus-leukemia properties Blood. 89: 3477-3485. PMID 9129056 DOI: 10.1182/Blood.V89.9.3477 |
0.492 |
|
| 1997 |
Khanna C, Anderson PM, Hasz DE, Katsanis E, Neville M, Klausner JS. Interleukin-2 liposome inhalation therapy is safe and effective for dogs with spontaneous pulmonary metastases Cancer. 79: 1409-1421. PMID 9083164 DOI: 10.1002/(Sici)1097-0142(19970401)79:7<1409::Aid-Cncr19>3.0.Co;2-3 |
0.302 |
|
| 1997 |
Saltzman DA, Katsanis E, Heise CP, Hasz DE, Vigdorovich V, Kelly SM, Curtiss R, Leonard AS, Anderson PM. Antitumor mechanisms of attenuated Salmonella typhimurium containing the gene for human interleukin-2: a novel antitumor agent? Journal of Pediatric Surgery. 32: 301-6. PMID 9044141 DOI: 10.1016/S0022-3468(97)90198-6 |
0.5 |
|
| 1996 |
Orchard PJ, Katsanis E, Boyer M, May C, McIvor RS, Blazar BR. Interleukin-2 secretion by transduced and unselected BDL-2 lymphoma results in increased survival in mice with previously established disseminated disease. Cancer Biotherapy & Radiopharmaceuticals. 11: 155-64. PMID 10851532 DOI: 10.1089/Cbr.1996.11.155 |
0.439 |
|
| 1996 |
Katsanis E, Xu Z, Panoskaltsis-Mortari A, Weisdorf DJ, Widmer MB, Blazar BR. IL-15 administration following syngeneic bone marrow transplantation prolongs survival of lymphoma bearing mice Transplantation. 62: 872-875. PMID 8824494 DOI: 10.1097/00007890-199609270-00031 |
0.39 |
|
| 1996 |
Bausero MA, Panoskaltsis-Mortari A, Blazar BR, Katsanis E. Effective immunization against neuroblastoma using double-transduced tumor cells secreting GM-CSF and interferon-γ Journal of Immunotherapy. 19: 113-124. PMID 8732694 DOI: 10.1097/00002371-199603000-00004 |
0.458 |
|
| 1995 |
Katsanis E, Xu Z, Bausero MA, Dancisak BB, Gorden KB, Davis G, Gray GS, Orchard PJ, Blazar BR. B7-1 expression decreases tumorigenicity and induces partial systemic immunity to murine neuroblastoma deficient in major histocompatibility complex and costimulatory molecules Cancer Gene Therapy. 2: 39-46. PMID 7542553 |
0.331 |
|
| 1994 |
Katsanis E, Orchard PJ, Bausero MA, Gorden KB, McIvor RS, Blazar BR. Interleukin-2 gene transfer into murine neuroblastoma decreases tumorigenicity and enhances systemic immunity causing regression of preestablished retroperitoneal tumors. Journal of Immunotherapy With Emphasis On Tumor Immunology : Official Journal of the Society For Biological Therapy. 15: 81-90. PMID 8136949 DOI: 10.1097/00002371-199402000-00001 |
0.495 |
|
| 1994 |
Katsanis E, Blazar BR, Bausero MA, Gunther R, Anderson PM. Retroperitoneal inoculation of murine neuroblastoma results in a reliable model for evaluation of the antitumor immune response Journal of Pediatric Surgery. 29: 538-542. PMID 8014811 DOI: 10.1016/0022-3468(94)90086-8 |
0.481 |
|
| 1994 |
Katsanis E, Weisdorf DJ, Xu Z, Dancisak BB, Halet ML, Blazar BR. Infusions of interleukin-1α after autologous transplantation for Hodgkin's disease and non-Hodgkin's lymphoma induce effector cells with antilymphoma cytolytic activity Journal of Clinical Immunology. 14: 205-211. PMID 7929695 DOI: 10.1007/Bf01533369 |
0.351 |
|
| 1994 |
Katsanis E, Xu Z, Anderson PM, Dancisak BB, Bausero MA, Weisdorf DJ, Blazar BR, Ochoa AC. Short-term ex vivo activation of splenocytes with anti-CD3 plus IL-2 and infusion post-BMT into mice results in in vivo expansion of effector cells with potent anti-lymphoma activity Bone Marrow Transplantation. 14: 563-572. PMID 7858530 |
0.421 |
|
| 1991 |
Katsanis E, Anderson PM, Filipovich AH, Hasz DE, Rich ML, Loeffler CM, Ochoa AC, Weisdorf DJ. Proliferation and cytolytic function of anti-CD3 + interleukin-2 stimulated peripheral blood mononuclear cells following bone marrow transplantation. Blood. 78: 1286-91. PMID 1831682 DOI: 10.1182/Blood.V78.5.1286.1286 |
0.438 |
|
| 1991 |
Loeffler CM, Platt JL, Anderson PM, Katsanis E, Ochoa JB, Urba WJ, Longo DL, Leonard AS, Ochoa AC. Antitumor effects of interleukin 2 liposomes and anti-CD3-stimulated T-cells against murine MCA-38 hepatic metastasis. Cancer Research. 51: 2127-32. PMID 1826232 |
0.38 |
|
| 1991 |
Sencer SF, Rich ML, Katsanis E, Ochoa AC, Anderson PM. Anti-tumor vaccine adjuvant effects of IL-2 liposomes in mice immunized against MCA-102 sarcoma European Cytokine Network. 2: 311-318. PMID 1804322 |
0.37 |
|
| 1991 |
Katsanis E, Bausero MA, Ochoa AC, Loeffler CM, Blazar BR, Leonard AS, Anderson PM. Importance in timing of cyclophosphamide on the enhancement of interleukin-2-induced cytolysis. Cancer Immunology, Immunotherapy : Cii. 34: 74-8. PMID 1760819 DOI: 10.1007/Bf01741339 |
0.415 |
|
| 1991 |
Anderson PM, Katsanis E, Hasz D, Weisdorf D. Development of specific T cell medicated anti-B lineage ALL cellular immunity using in vivo interleukin-2 after autologous bone marrow transplant Journal of Pediatric Hematology Oncology. 13: 97. DOI: 10.1097/00043426-199121000-00022 |
0.413 |
|
| 1991 |
Katsanis E, Ochoa A, Bausero MA, Anderson PM, Ramsay NKC. Effect of interleukin-2 and cyclophosphamide on the antitumor immune response against murine neuro-blastoma Journal of Pediatric Hematology Oncology. 13: 97. DOI: 10.1097/00043426-199121000-00021 |
0.384 |
|
| Show low-probability matches. |